Synthetic Biology
An interdisciplinary field combining principles from biology and engineering that involves designing and constructing new biological parts, devices, and systems, or redesigning existing biological systems, with applications in drug development, enzyme engineering, and vaccine design.
Core Facts
Risks in the biological domain are primarily concentrated in AI-assisted synthetic biology, namely using models to lower the knowledge barriers to designing or acquiring dangerous biological agents.
The AlphaFold series is used for protein structure prediction, and genomic language models are used for DNA sequence design, greatly accelerating the synthetic biology process.
Timeline (last 90 days)
In the de-extinction pathway, CRISPR is responsible for changing, synthetic biology is responsible for building and regulating, and AI is responsible for searching for feasible solutions among the vast space of possible options; de-extinction is seen as a systems engineering effort highly dependent on interdisciplinary infrastructure.
Colossal Biosciences was founded by Ben Lamm and George Church, with the core goal of using CRISPR gene editing, stem cell technology and synthetic biology methods to bring extinct species back to Earth.
Synthetic biology is attempting to engineer the features of self-replication, programmability and distributed manufacturing, for example by building self-replicating artificial cells or phages.
Risks in the biological domain are primarily concentrated in AI-assisted synthetic biology, namely using models to lower the knowledge barriers to designing or acquiring dangerous biological agents.
The transition from laboratory to industrial-scale production faces obstacles including circuit instability caused by cellular metabolic burden, product accumulation toxicity, and inter-batch genetic stability.
Synthetic biology draws on the idea of standardized components from electrical engineering, treating functional modules such as promoters, ribosome binding sites, and coding sequences as reusable BioBricks.
The AlphaFold series is used for protein structure prediction, and genomic language models are used for DNA sequence design, greatly accelerating the synthetic biology process.
All Facts (7)
Risks in the biological domain are primarily concentrated in AI-assisted synthetic biology, namely using models to lower the knowledge barriers to designing or acquiring dangerous biological agents.
75%VerifiedThe AlphaFold series is used for protein structure prediction, and genomic language models are used for DNA sequence design, greatly accelerating the synthetic biology process.
75%UnverifiedColossal Biosciences was founded by Ben Lamm and George Church, with the core goal of using CRISPR gene editing, stem cell technology and synthetic biology methods to bring extinct species back to Earth.
50%UnverifiedIn the de-extinction pathway, CRISPR is responsible for changing, synthetic biology is responsible for building and regulating, and AI is responsible for searching for feasible solutions among the vast space of possible options; de-extinction is seen as a systems engineering effort highly dependent on interdisciplinary infrastructure.
50%UnverifiedSynthetic biology is attempting to engineer the features of self-replication, programmability and distributed manufacturing, for example by building self-replicating artificial cells or phages.
50%UnverifiedSynthetic biology draws on the idea of standardized components from electrical engineering, treating functional modules such as promoters, ribosome binding sites, and coding sequences as reusable BioBricks.
50%UnverifiedThe transition from laboratory to industrial-scale production faces obstacles including circuit instability caused by cellular metabolic burden, product accumulation toxicity, and inter-batch genetic stability.
50%